Imaflex Stock Current Valuation
| IFX Stock | CAD 1.46 0.02 1.35% |
Valuation analysis of Imaflex helps investors to measure Imaflex's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value Over EBITDA is likely to climb to 8.69 in 2024. Enterprise Value Multiple is likely to climb to 8.69 in 2024. Fundamental drivers impacting Imaflex's valuation include:
Price Book 1.2342 | Enterprise Value 86.9 M | Enterprise Value Ebitda 7.6392 | Price Sales 0.7449 | Forward PE 9.1241 |
Undervalued
Today
Please note that Imaflex's price fluctuation is dangerous at this time. Calculation of the real value of Imaflex is based on 3 months time horizon. Increasing Imaflex's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Imaflex stock is determined by what a typical buyer is willing to pay for full or partial control of Imaflex. Since Imaflex is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Imaflex Stock. However, Imaflex's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.46 | Real 1.58 | Hype 1.45 | Naive 1.45 |
The intrinsic value of Imaflex's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Imaflex's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Imaflex helps investors to forecast how Imaflex stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Imaflex more accurately as focusing exclusively on Imaflex's fundamentals will not take into account other important factors: Imaflex Company Current Valuation Analysis
Imaflex's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Imaflex Current Valuation | 86.88 M |
Most of Imaflex's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Imaflex is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Imaflex Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Imaflex is extremely important. It helps to project a fair market value of Imaflex Stock properly, considering its historical fundamentals such as Current Valuation. Since Imaflex's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Imaflex's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Imaflex's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Imaflex has a Current Valuation of 86.88 M. This is 99.52% lower than that of the Containers & Packaging sector and 98.98% lower than that of the Materials industry. The current valuation for all Canada stocks is 99.48% higher than that of the company.
Imaflex Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Imaflex's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Imaflex could also be used in its relative valuation, which is a method of valuing Imaflex by comparing valuation metrics of similar companies.Imaflex is currently under evaluation in current valuation category among its peers.
Imaflex Current Valuation Drivers
We derive many important indicators used in calculating different scores of Imaflex from analyzing Imaflex's financial statements. These drivers represent accounts that assess Imaflex's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Imaflex's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 32.5M | 52.0M | 61.3M | 79.1M | 46.2M | 48.5M | |
| Enterprise Value | 48.9M | 58.6M | 62.4M | 79.6M | 56.8M | 59.6M |
Imaflex Fundamentals
| Return On Equity | 0.0749 | ||||
| Return On Asset | 0.051 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 86.88 M | ||||
| Shares Outstanding | 52.09 M | ||||
| Shares Owned By Insiders | 44.78 % | ||||
| Shares Owned By Institutions | 10.16 % | ||||
| Number Of Shares Shorted | 4.37 K | ||||
| Price To Earning | 11.04 X | ||||
| Price To Book | 1.23 X | ||||
| Price To Sales | 0.74 X | ||||
| Revenue | 93.59 M | ||||
| Gross Profit | 18.05 M | ||||
| EBITDA | 7.57 M | ||||
| Net Income | 508.78 K | ||||
| Cash And Equivalents | 328 K | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 11.41 M | ||||
| Debt To Equity | 60.90 % | ||||
| Current Ratio | 1.58 X | ||||
| Book Value Per Share | 1.18 X | ||||
| Cash Flow From Operations | 4.88 M | ||||
| Short Ratio | 0.44 X | ||||
| Earnings Per Share | 0.08 X | ||||
| Target Price | 1.95 | ||||
| Number Of Employees | 268 | ||||
| Beta | 0.34 | ||||
| Market Capitalization | 76.05 M | ||||
| Total Asset | 83.48 M | ||||
| Retained Earnings | 39.93 M | ||||
| Working Capital | 13.99 M | ||||
| Net Asset | 83.48 M |
About Imaflex Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Imaflex's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Imaflex using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Imaflex based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Imaflex Stock Analysis
When running Imaflex's price analysis, check to measure Imaflex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imaflex is operating at the current time. Most of Imaflex's value examination focuses on studying past and present price action to predict the probability of Imaflex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imaflex's price. Additionally, you may evaluate how the addition of Imaflex to your portfolios can decrease your overall portfolio volatility.